Funding for this research was provided by:
Department for International Development, UK Government (ReBUILD RPC)
Text and Data Mining valid from 2019-07-15
Received: 19 February 2019
Accepted: 24 June 2019
First Online: 15 July 2019
Ethics approval and consent to participate
: Ethics approval was obtained from Queen Margaret University’s Research Ethics Panel, as well as the Medical Research Council of Zimbabwe (MRCZ/A/2265). The study also received authorisation from the MoHCC in Zimbabwe. Informed consent was obtained from all participants.
: Not applicable.
: In the interests of transparency, SW led a health system assessment in Zimbabwe in 2016–17, which included making suggested reforms to the RBF programme, alongside human resource and pharmaceutical supply and management policies. However, the authors report no conflict of interest in relation to this article.